Variability of core microbiota in newly diagnosed treatment-naïve paediatric inflammatory bowel disease patients.
BACKGROUND & AIMS:Intestinal microbiota is considered to play a crucial role in the aetiology of inflammatory bowel disease (IBD). We aimed to describe faecal microbiota composition and dynamics in a large cohort of children with de novo (naïve) IBD, in comparison to healthy paediatric controls...
Main Authors: | T G J de Meij, E F J de Groot, C F W Peeters, N K H de Boer, C M F Kneepkens, A Eck, M A Benninga, P H M Savelkoul, A A van Bodegraven, A E Budding |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC6089417?pdf=render |
Similar Items
-
Vedolizumab in paediatric Inflammatory Bowel Disease: A retrospective multi-centre experience From the paediatric IBD Porto Group of ESPGHAN
by: Ledder, O, et al.
Published: (2017) -
Vedolizumab in pediatric inflammatory bowel disease: a retrospective multi-center experience from the Paediatric IBD Porto group of ESPGHAN
by: Ledder, O, et al.
Published: (2017) -
Vedolizumab in Pediatric inflammatory bowel diseases: a retrospective multi-center experience from the paediatric IBD Porto group of ESPGHAN
by: Ledder, O, et al.
Published: (2017) -
Identification of a Disease-Associated Network of Intestinal Immune Cells in Treatment-Naive Inflammatory Bowel Disease
by: Vincent van Unen, et al.
Published: (2022-06-01) -
Prediction of Inflammatory Bowel Disease Course Based on Fecal Scent
by: Sofie Bosch, et al.
Published: (2022-03-01)